[Evaluation of value of procalcitonin determination in assessing the severity of bacterial infection in critically ill patients requiring anti-coagulant therapy].
Xu
Kan
K
Kang
Fu-xin
FX
Wang
Rui-lan
RL
D000925:Anticoagulants / Q000627:therapeutic use; D001424:Bacterial Infections / Q000097:blood* / Q000188:drug therapy; D002097:C-Reactive Protein / Q000378:metabolism; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D016638:Critical Illness; D005260:Female; D006801:Humans; D008297:Male; D011498:Protein Precursors / Q000097:blood*
D000925:Anticoagulants; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D002097:C-Reactive Protein; D015740:Calcitonin Gene-Related Peptide